Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CLOBETASOL PROPIONATE | Eyenovia | N-218158 RX | 2024-03-04 | 1 products, RLD, RS |
CLOBEX | Galderma | N-021644 RX | 2004-02-05 | 1 products, RLD, RS |
CLOBEX | Galderma | N-021535 RX | 2003-07-24 | 1 products, RLD, RS |
CLOBEX | Galderma | N-021835 RX | 2005-10-27 | 1 products, RLD, RS |
IMPOYZ | Primus Pharmaceuticals | N-209483 RX | 2017-11-28 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
calcipotriene 0.005% / clobetasol propionate 0.05% | unapproved drug other | 2019-05-20 |
ciclopirox 1% / clobetasol propionate 0.05% | unapproved drug other | 2019-04-24 |
ciclopirox olamine 0.77% / clobetasol propionate 0.05% / salicylic acid 3%. | unapproved drug other | 2019-05-16 |
clobetasol propionate | ANDA | 2025-03-26 |
clobetasol propionate (emollient) | ANDA | 2021-07-01 |
clobetasol propionate 0.05% / coal tar 8% / salicylic acid 6% | unapproved drug other | 2019-05-14 |
clobetasol propionate 0.05% / levocetirizine dihydrochloride 2% | unapproved drug other | 2019-05-16 |
clobetasol propionate 0.05% / niacinamide 4% | unapproved drug other | 2019-05-02 |
clobetasol propionate cream usp, 0.05% | ANDA | 2024-11-08 |
clobetasol propionate cream, 0.05% | ANDA | 2024-08-01 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
inflammation | MP_0001845 | D007249 | — |
dermatitis | — | D003872 | L30.9 |
facial dermatoses | — | D005148 | — |
foot dermatoses | — | D005533 | — |
hand dermatoses | — | D006229 | — |
scalp dermatoses | — | D012536 | — |
leg dermatoses | — | D007868 | — |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Clobetasol Propionate, Impoyz, Primus Pharms | |||
9855334 | 2035-03-11 | DP | |
9956231 | 2030-08-31 | DP | U-88, U-193, U-742, U-1408, U-1761, U-1858 |
10064875 | 2030-08-31 | DP | U-88, U-193, U-742, U-1408, U-1858 |
10588914 | 2030-08-31 | DP | U-2771 |
Clobetasol Propionate, Olux E, Mylan | |||
8460641 | 2028-11-05 | DP | U-1410 |
8962000 | 2025-08-31 | DP | U-1410 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 3 | — | — | — | — | 3 |
Drug common name | Clobetasol propionate |
INN | clobetasol |
Description | Clobetasol propionate is the 17-O-propionate ester of clobetasol. A potent corticosteroid, it is used to treat various skin disorders, including exzema and psoriasis. It has a role as an anti-inflammatory drug. It is an 11beta-hydroxy steroid, a 20-oxo steroid, a glucocorticoid, a fluorinated steroid, a 3-oxo-Delta(1),Delta(4)-steroid and a chlorinated steroid. It is functionally related to a clobetasol and a propionic acid. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C |
PDB | — |
CAS-ID | 25122-46-7 |
RxCUI | — |
ChEMBL ID | CHEMBL1159650 |
ChEBI ID | 31414 |
PubChem CID | 32798 |
DrugBank | DB01013 |
UNII ID | 779619577M (ChemIDplus, GSRS) |